Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2025-12-24 @ 12:19 PM
NCT ID:
NCT03416361
Eligibility Criteria:
Inclusion Criteria:
* LVSD (LVEF \<50%);
* stable medical and device therapy for \>3mths;
* 25\[OH\]vitamin D3 \<50nmol/L
* At least one of: recent (\<1 year) hospitalisation for HF, high dose loop diuretic requirement (\>80mg daily furosemide equiv), diabetes mellitus, ischaemic aetiology
Exclusion Criteria:
* Unwilling/unable to sign consent,
* Severe cognitive impairment,
* Severe COPD,
* Anaemia,
* Other life-threatening co-morbidity (in the opinion of the local co-investigator),
* Known and active sarcoidosis or tuberculosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03416361
Study Brief:
Protocol Section:
NCT03416361